Investing Profile

George C. Petrocheilos

InvestorVCFounder
Co-Founder & Managing Partner at Catalio Capital Management
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
8
CompanyStageDateRound SizeTotal Raised
Clasp Therapeutics
Series AMar 2024$150M
$150M
Co-investors: R. Jacob Vogelstein (Catalio Capital), Andrea van Elsas (Third Rock Ventures), Jack Nielsen (Vivo Capital)
Haystack Oncology
Series ANov 2022$56M
$56M
Co-investors: R. Jacob Vogelstein (Catalio Capital)
Anagenex
Series AJun 2022$30M
$30M
Co-investors: Zavain Dar (Dimension Capital)
Pheast Therapeutics
Series AApr 2022$76M
$76M
Co-investors: R. Jacob Vogelstein (Catalio Capital), Steven Gillis (ARCH Venture Partners)
Octant Bio
Series BApr 2022$80M
$200M
Co-investors: Katie Haun (Haun Ventures), Jorge Conde (Andreessen Horowitz), Lars Fjeldsoe-Nielsen (2xN), Clint Korver (Ulu Ventures), Miriam Rivera (Ulu Ventures), Shawn Dimantha (Angel investor), Stephen Hays (What If Ventures), Sujay Jaswa (WndrCo LLC), Ling Wong (Highbury Group)
DNA Script
Series COct 2021$170M
$270M
Co-investors: Joachim Rothe (EQT Life Sciences), Nick Naclerio (Illumina Ventures), Eli Casdin (Casdin Capital), Joško Bobanović (Sofinnova Partners), Philippe Peltier (Kurma Partners)
Sensei Biotherapeutics
Series BJan 2021$30M
$59M
Co-investors: Christian Angermayer (Presight Capital)
Spiral Therapeutics
Series ADec 2018$6M
$6M
Co-investors: Sara Secall (Inveready Technology Investment Group)
Co-Founder & Managing Partner Catalio Capital Management2020 - Present
General Partner Camden Partners2014 - 2020
Analyst - Project Finance Constellation Energy2011 - 2011